Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALUE phase 3 trial of EscharEx EX03 for debridement of venous leg ulcers
MOH_2025-05-13_014089Phase 3Not yet recruiting
- Sponsor
- MediWound
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stasis ulcer comparing EscharEx EX03 with Placebo (2 arms). Planned start May 2025; status: not yet recruiting.
02
Drugs
EscharEx
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on MOH_2025-05-13_014089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-05-13_014089.